Lauren E. Black

1.4k total citations
12 papers, 295 citations indexed

About

Lauren E. Black is a scholar working on Immunology, Small Animals and Molecular Biology. According to data from OpenAlex, Lauren E. Black has authored 12 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Small Animals and 3 papers in Molecular Biology. Recurrent topics in Lauren E. Black's work include Immunotoxicology and immune responses (4 papers), Biosimilars and Bioanalytical Methods (4 papers) and Animal testing and alternatives (4 papers). Lauren E. Black is often cited by papers focused on Immunotoxicology and immune responses (4 papers), Biosimilars and Bioanalytical Methods (4 papers) and Animal testing and alternatives (4 papers). Lauren E. Black collaborates with scholars based in United States, United Kingdom and Netherlands. Lauren E. Black's co-authors include Kathryn Chapman, Jessica A. Couch, Alexander Jordan, Cheol-Hee Ahn, Joy Cavagnaro, Stuart Creton, Sean C. Gehen, Henry H. Holzgrefe, Lewis B. Kinter and Marilyn J. Brown and has published in prestigious journals such as Nature reviews. Immunology, Regulatory Toxicology and Pharmacology and Toxicologic Pathology.

In The Last Decade

Lauren E. Black

12 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lauren E. Black United States 9 107 93 78 43 39 12 295
Hendrik Reuter Germany 9 36 0.3× 110 1.2× 44 0.6× 7 0.2× 17 0.4× 16 295
Jessica Löffler Germany 10 36 0.3× 98 1.1× 12 0.2× 25 0.6× 35 0.9× 14 259
R. James Brawn United States 8 166 1.6× 152 1.6× 12 0.2× 63 1.5× 83 2.1× 10 397
Anita J. Nelsen United States 7 33 0.3× 208 2.2× 6 0.1× 13 0.3× 21 0.5× 9 349
Scott B. Seibel United States 8 65 0.6× 65 0.7× 46 0.6× 16 0.4× 45 1.2× 15 326
Ayesha Bhatia United States 10 54 0.5× 281 3.0× 6 0.1× 16 0.4× 24 0.6× 11 405
Caifeng Chen China 11 113 1.1× 149 1.6× 5 0.1× 21 0.5× 61 1.6× 24 328
B. Vincze Hungary 11 42 0.4× 123 1.3× 13 0.2× 15 0.3× 49 1.3× 34 364
Nina Senutovitch United States 6 8 0.1× 123 1.3× 15 0.2× 12 0.3× 47 1.2× 6 455
E. W. Breitbart Germany 9 27 0.3× 123 1.3× 5 0.1× 11 0.3× 115 2.9× 19 344

Countries citing papers authored by Lauren E. Black

Since Specialization
Citations

This map shows the geographic impact of Lauren E. Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren E. Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren E. Black more than expected).

Fields of papers citing papers by Lauren E. Black

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren E. Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren E. Black. The network helps show where Lauren E. Black may publish in the future.

Co-authorship network of co-authors of Lauren E. Black

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren E. Black. A scholar is included among the top collaborators of Lauren E. Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren E. Black. Lauren E. Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Templin, Michael V., et al.. (2022). RNA-based drug discovery for spinal muscular atrophy: a story of small molecules and antisense oligonucleotides. Expert Opinion on Drug Discovery. 18(2). 181–192. 4 indexed citations
2.
Brennan, Frank R., Joy Cavagnaro, Kathleen McKeever, et al.. (2017). Safety testing of monoclonal antibodies in non-human primates: Case studies highlighting their impact on human risk assessment. mAbs. 10(1). 1–17. 48 indexed citations
3.
Chapman, Kathryn, Henry H. Holzgrefe, Lauren E. Black, et al.. (2013). Pharmaceutical toxicology: Designing studies to reduce animal use, while maximizing human translation. Regulatory Toxicology and Pharmacology. 66(1). 88–103. 99 indexed citations
4.
Horvath, Christopher, Laura Andrews, Andreas Baumann, et al.. (2012). Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trial. Nature reviews. Immunology. 12(10). 740–740. 27 indexed citations
5.
Lebrec, Hervé, Cecile M. Krejsa, Moni B. Neradilek, et al.. (2011). An inter-laboratory retrospective analysis of immunotoxicological endpoints in non-human primates: T-cell-dependent antibody responses. Journal of Immunotoxicology. 8(3). 238–250. 9 indexed citations
6.
Chapman, Kathryn, Laura Andrews, Jeffrey J. Bajramović, et al.. (2011). The design of chronic toxicology studies of monoclonal antibodies: Implications for the reduction in use of non-human primates. Regulatory Toxicology and Pharmacology. 62(2). 347–354. 31 indexed citations
7.
Lappin, Patrick B. & Lauren E. Black. (2003). Immune Modulator Studies in Primates: The Utility of Flow Cytometry and Immunohistochemistry in the Identification and Characterization of Immunotoxicity. Toxicologic Pathology. 31(1_suppl). 111–118. 13 indexed citations
8.
Black, Lauren E., Anthony D. Dayan, Joy Cavagnaro, et al.. (2000). Safety evaluation of immunomodulatory biopharmaceuticals: can we improve the predictive value of preclinical studies?. Human & Experimental Toxicology. 19(4). 205–207. 3 indexed citations
9.
Black, Lauren E., et al.. (2000). Status of preclinical safety assessment for immunomodulatory biopharmaceuticals. Human & Experimental Toxicology. 19(4). 208–212. 8 indexed citations
10.
11.
Black, Lauren E., James G. Farrelly, Cheol-Hee Ahn, et al.. (1994). Regulatory Considerations for Oligonucleotide Drugs: Updated Recommendations for Pharmacology and Toxicology Studies. PubMed. 4(4). 299–301. 33 indexed citations
12.
Black, Lauren E., et al.. (1993). Regulatory Considerations for Evaluating the Pharmacology and Toxicology of Antisense Drugs. PubMed. 3(4). 399–404. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hendrik Reuter Breakdown of academic impact, for papers by Jessica Löffler Breakdown of academic impact, for papers by R. James Brawn Breakdown of academic impact, for papers by Anita J. Nelsen Breakdown of academic impact, for papers by Scott B. Seibel Breakdown of academic impact, for papers by Ayesha Bhatia Breakdown of academic impact, for papers by Caifeng Chen Breakdown of academic impact, for papers by B. Vincze Breakdown of academic impact, for papers by Nina Senutovitch Breakdown of academic impact, for papers by E. W. Breitbart
Rankless by CCL
2026